Scholarly Index
Anna Maria Langkilde
AstraZeneca (Sweden); 17,039 total citations; 241 total publications; best world rank #69
AstraZeneca (Sweden)
17,039Total citations
241Total publications
64H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Diabetes Treatment and Management | Lifetime | 525 | SE 13 | 98.13 |
| Pancreatic function and diabetes | 2021-2025 | 69 | SE 1 | 98.31 |
| Diabetes Treatment and Management | 2021-2025 | 114 | SE 2 | 98.70 |
| Heart Failure Treatment and Management | 2021-2025 | 216 | SE 5 | 97.42 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 508 | SE 11 | 86.91 |
| Chronic Kidney Disease and Diabetes | 2021-2025 | 792 | SE 16 | 85.12 |
| Erythropoietin and Anemia Treatment | 2021-2025 | 429 | SE 4 | 69.55 |
| Potassium and Related Disorders | 2021-2025 | 803 | SE 29 | 57.82 |